Gut Bacteria Hydrogen Production Linked to High Blood Pressure Risk
- Authors
- Yang Yi, Fei Xie, Chao Xia, Junyu Li, Pengxiang Zhao, Mengyu Liu, Xuemei Ma, Jinfeng Chen
- Journal
- Medical Gas Research
- Year
- 2026
- DOI
- 10.4103/mgr.MEDGASRES-D-25-00128
- Study Type
- Human
- Outcome
- Neutral
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Hypertension
- Body System
- Cardiovascular
TL;DR
Hypertension was associated with distinct gut microbial hydrogenase patterns, while genetic analysis suggested hydrogen metabolism may be protective.
Key Finding
People with hypertension showed significantly altered patterns of specific bacterial hydrogenase enzymes compared to those without high blood pressure, with three enzyme subtypes potentially serving as diagnostic markers for hypertension.
Summary
This study analyzed gut bacteria genes in people with and without high blood pressure to understand how bacterial hydrogen metabolism relates to hypertension. Researchers found that people with high blood pressure had different patterns of specific bacterial enzymes (called hydrogenases) that produce and use hydrogen. Statistical analysis suggested that better hydrogen metabolism in gut bacteria may be protective against high blood pressure.
Practical Takeaway
This is an early-stage analysis of existing genetic data that suggests a link between gut bacterial hydrogen metabolism and blood pressure regulation. However, this study does not test hydrogen water directly—it examines natural hydrogen production by gut bacteria. Much more research is needed before any therapeutic recommendations can be made, and the findings do not yet support using hydrogen water as a hypertension treatment.
Abstract
Hypertension is a prevalent chronic condition and serves as a significant risk factor for numerous cardiovascular and cerebrovascular disorders. Gut microbiota dysbiosis has been considered to contribute to the pathogenesis of hypertension. It has been reported that a large majority of gut microbiota possess genes encoding hydrogenases. These hydrogenases are involved in the alteration of gut microbiota in non-infectious colitis, suggesting a potential link between microbial hydrogen metabolism and disease onset. This study aims to explore the relationship between hydrogenase expression patterns in the gut microbiome and the incidence of hypertension. In this study, publicly available gut microbiome metagenomic data were used to comprehensively analyze the expression patterns of hydrogenases in the gut microbiota of hypertensive patients. Compared with the control group, a 2.3-fold increase in electron bifurcating [FeFe] group A3 hydrogenases (P = 0.0299), a 55.6% decrease in [NiFe] group 1d hydrogenases (P = 0.0097), increased hydrogen-sensing hydrogenases and decreased hydrogen-uptake hydrogenases in the hypertension group. The main difference between the two groups is reflected in the abundance of [NiFe] hydrogenase subtypes. After eliminating the effects of factors such as age, sex, and lifestyle, significant differences in the abundance of [FeFe] group A3, [NiFe] group 1d, and [NiFe] group 1c were observed between the two groups, suggesting that these three indicators could serve as potential biomarkers for diagnosing the onset of hypertension. Additionally, Mendelian randomization analysis showed a protective effect of hydrogen metabolism against hypertension (odds ratio = 0.72, 95% confidence interval: 0.61-0.85, P < 0.001). Our study advances the understanding of microbiome-mediated mechanisms in hypertension by demonstrating an association between hydrogenase expression dynamics and blood pressure regulation, providing a foundation for future microbiome-based diagnostic and therapeutic strategies.